Dr. Tomasz J. Kuzniar, MD

Dr. Kuzniar practices at Northshore University Healthsystem Faculty Practice Associates in Glenview, Illinois.

Dr. Kuzniar's NPI, 1114905171, was assigned on January 9, 2006. Dr. Kuzniar graduated from Wroclaw Medical University in 1993. Dr. Kuzniar's Minnesota license number on file is 47702.

Dr. Kuzniar's primary practice is Northshore University Healthsystem Faculty Practice Associates, at 2180 Pfingsten Rd, Glenview, IL 60026 in Cook County. The practice phone is (847) 570-5235.

Dr. Kuzniar's primary practice is Northshore University Healthsystem Faculty Practice Associates in Glenview, Illinois. Dr. Kuzniar is also affiliated with Evanston Hospital. The medical group on file is Endeavor Health Medical Group. Dmand AI also links Dr. Kuzniar to 2 more hospitals, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kuzniar practices, 3 sites in all. Vendor and product names are available with a free account.

Pulmonary disease is Dr. Kuzniar's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Dr. Kuzniar is board certified in critical care medicine by the American Board of Internal Medicine. Dmand AI has Dr. Kuzniar's licenses on file in 2 states: Minnesota and Illinois.

Dmand AI lists asthma, chronic lung disease, chronic obstructive pulmonary disease (COPD), chronic respiratory failure, pleural effusion, pneumonia, pulmonary fibrosis and sleep apnea among the conditions Dr. Kuzniar treats.

CMS data shows 2,172 Medicare services from Dr. Kuzniar across 17 procedure codes in 2024, for 914 Medicare patients. Medicare paid $141,158 for them.

CMS counts 914 Medicare patients who saw Dr. Kuzniar in 2024. The largest group is 75 to 84, with 358 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 14% are also on Medicaid. Their average risk score is 2.01, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Kuzniar's median patient age at 70, with 47% women.

In 2024, Dr. Kuzniar wrote 1,716 Medicare Part D claims for 270 patients. 40% of them were for generic drugs. CMS names the drug for 1,587 of them, across 31 drugs with 11 or more claims each, at $1,037,570 in total drug cost. In 2023, CMS named 1,589 claims across 29 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 85 out of 100 for Dr. Kuzniar for performance year 2024, reported as part of a group. Dr. Kuzniar accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Kuzniar as offering telehealth.

Dmand AI links 21 papers to Dr. Kuzniar, published from 2010 to 2020. 2010 was the busiest year, with 3. The most frequent topics are Continuous Positive Airway Pressure, Polysomnography and Sleep Apnea Syndromes. Dr. Kuzniar has published most often in Chest. Dr. Kuzniar's most frequent co-authors are Phillip Howard Factor, DO, Thomas A. Hensing, MD and Ayodeji O. Adegunsoye.

CMS Open Payments shows 141 general payments to Dr. Kuzniar from 20 drug and device companies from 2017 to 2025. Speaker and faculty fees make up the largest share, 83% of the total. Eli Lilly and Company paid the most, $92,582.

Dmand AI lists 1 award for Dr. Kuzniar, most recently CMS Stage 1 EHR in 2013.

Dr. Kuzniar graduated from Wroclaw Medical University in 1993. Dr. Kuzniar is a member of AASM, ACCP and AMA.

Dr. Kuzniar is in network with 17 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.